// App-Quantinova.ai

Filters

Biomarkers

No records found for your search

Conference Name

No records found for your search

Country

























Company

Search valid company name..

Conference Year













Drug











Disease

Medical Centers

Search valid medical center name..

Outcomes





Presenter

Search valid presenter name..

Principal Investigators

Search valid principal investigator name..

Phase










Patient Segments

Search valid patient segment..

Result



Sponsor

Search valid sponsor name..

Study ID

Search your valid Study ID..

Therapeutic Area
























28841 Abstracts

Concordance of a Modified Downes’ Score by Physicians and Nurses When Assessing Respiratory Distress Syndrome in the Ethiopian Neonatal Network

Danielle Ehret - Pediatric Academic Societies (PAS) , 2022

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Infant Respiratory Distress Syndrome

N/A

Correlates of Community Services Navigation Use Among Pediatric Patients with Health-Related Social Needs

Katarina Zumwalt - Pediatric Academic Societies (PAS) , 2022

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Cross-site comparisons of early exposure to analgesic medications in preterm neonates

Pearl Zaki - Pediatric Academic Societies (PAS) , 2022

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

Morphine

Current Epidemiology and Factors Contributing to Extrauterine Growth Retardation in Infants Born at Less than 32 Weeks’ Gestation in China

Yanyu Lyu - Pediatric Academic Societies (PAS) , 2022

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Early Cardiac Function and Pulmonary Hypertension are Associated with Adverse Cardio-Respiratory Outcomes in Extreme Preterms

Shiran Sara Moore - Pediatric Academic Societies (PAS) , 2022

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Pulmonary arterial hypertension

N/A

Effect of early skin-to-skin contact on skin colonization in preterm infants: A pre- and post-implementation study

Poorva Deshpande - Pediatric Academic Societies (PAS) , 2022

Therapeutic Area

Disease

Drug/Treatment

Obstetrics/Gynecology

Chorioamnionitis

N/A

Effect of Own Mother's Milk and Donor Human Milk on Aryl Hydrocarbon Receptor Activity in Very Low Birth Weight Infants

Prabhu S. Parimi - Pediatric Academic Societies (PAS) , 2022

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

tryptophan

Effectiveness and Safety of Tranexamic Acid in Pediatric Trauma: A Systematic Review and Meta-Analysis

Emily Kornelsen - Pediatric Academic Societies (PAS) , 2022

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Trauma

Tranexamic acid

Effectiveness of the Canadian Consensus Approach for Diagnosis and Grading of Preterm Brain Injury from Cranial Ultrasound

Lara M. Leijser - Pediatric Academic Societies (PAS) , 2022

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

White matter injury

N/A

Epidemiology and Management of Abdominal Injuries in Children

Pradip P. Chaudhari - Pediatric Academic Societies (PAS) , 2022

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Feedback in Endoscopy Education: Describing Barriers, Attitudes, Context and Knowledge (FEEDBACK): A qualitative study of pediatric gastroenterology trainees and faculty

Paul Tran - Pediatric Academic Societies (PAS) , 2022

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Global PARITY: Challenges and Lessons Learned Conducting a Global Point Prevalence Study in Resource-limited Settings During a Pandemic

Erika Miller - Pediatric Academic Societies (PAS) , 2022

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Acute lung injury

N/A

Grade 3 School Performance Among Children Born Preterm: A Population-Based Cohort Study in Canada

Deepak Louis - Pediatric Academic Societies (PAS) , 2022

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Hemodynamic profile of neonates receiving sildenafil in addition to therapeutic hypothermia for neonatal encephalopathy

Anie Lapointe - Pediatric Academic Societies (PAS) , 2022

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Hypoxic-ischemic encephalopathy

Sildenafil citrate

Impact of pulmonary hypertension on brain injury in term encephalopathic neonates treated with hypothermia

Keira C. Kilmartin - Pediatric Academic Societies (PAS) , 2022

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Pulmonary arterial hypertension

INO

Improving communication in the NICU: a qualitative descriptive study of parent and NICU clinician perspectives

Maya E. Dahan - Pediatric Academic Societies (PAS) , 2022

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Is Increased Resource Utilization Associated with Improved Neurodevelopmental Outcome in Hypoxic Ischemic Encephalopathy? A Report from the Children’s Hospitals Neonatal Consortium HIE Focus Group

Vilmaris Quinones Cardona - Pediatric Academic Societies (PAS) , 2022

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Hypoxic-ischemic encephalopathy

N/A

Maternal overweight and obesity’s impact on long-term neurodevelopmental outcomes in premature infants (<29 weeks) at 18-24 months corrected age

Marina Journault - Pediatric Academic Societies (PAS) , 2022

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Cerebral Palsy

N/A

Neonates treated with therapeutic hypothermia: is the absence of cord blood acidosis a marker for encephalopathy due to causes other than hypoxic-ischemic encephalopathy?

Marie-Coralie Cornet - Pediatric Academic Societies (PAS) , 2022

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Hypoxic-ischemic encephalopathy

N/A

Relationship between EEG and early neuromotor outcomes in preterm infants

Audrey Dufour - Pediatric Academic Societies (PAS) , 2022

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Copyright © 2026. QuantiNova All rights reserved